Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic contains semaglutide, a medication that mimics a natural hormone called GLP-1 in your body. Clinical trials show semaglutide users lose an average of 15% of their body weight over 68 weeks. PlexusDx offers compounded semaglutide injections as an affordable alternative to brand-name prescriptions, starting at $149 per month.
How Semaglutide Works to Reduce Hunger
Semaglutide is a GLP-1 receptor agonist, meaning it activates specific receptors in your brain and digestive system that control hunger signals. When semaglutide binds to these receptors, it slows gastric emptying—the speed at which food leaves your stomach—creating a prolonged feeling of fullness. This mechanism reduces cravings and makes it easier to eat smaller portions without constant hunger.
The medication also increases glucagon release when your blood sugar drops, helping prevent low glucose episodes. Research published in the New England Journal of Medicine found that participants using semaglutide ate approximately 350 fewer calories per day compared to placebo groups. This appetite suppression persists throughout treatment, making sustained weight loss more achievable than with diet and exercise alone.
The Active Ingredient and How It Differs from Insulin
Semaglutide is a peptide—a short chain of amino acids—not insulin. While both are injected medications, they work through completely different pathways. Insulin helps cells absorb glucose from the bloodstream, whereas semaglutide signals your brain to reduce appetite and helps regulate blood sugar indirectly by slowing digestion. This distinction is important because semaglutide does not cause the blood sugar crashes associated with insulin therapy.
Semaglutide was originally developed to treat type 2 diabetes and improve cardiovascular outcomes. Ozempic (the diabetes formulation) and Wegovy (the weight-loss formulation) contain identical semaglutide but are marketed for different purposes. PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies, delivering the same active ingredient at a more accessible price point without membership fees or insurance requirements.
Semaglutide's Effect on Blood Sugar and Metabolic Health
Beyond appetite suppression, semaglutide improves how your body manages glucose. It stimulates insulin secretion when blood sugar rises and promotes beta-cell function in the pancreas—the cells responsible for producing insulin. Clinical data shows semaglutide users experience improvements in hemoglobin A1C levels (a marker of long-term blood sugar control) and fasting glucose, even in people without diabetes.
This metabolic improvement often contributes to weight loss success. Better blood sugar stability reduces energy crashes and cravings for quick carbohydrates, creating a favorable environment for sustained calorie deficit. Users frequently report improved energy levels and reduced brain fog as their glucose regulation normalizes, making adherence to healthy habits less physically taxing.
Getting Compounded Semaglutide from PlexusDx
PlexusDx offers compounded semaglutide injections starting at $149 per month, with no insurance required and no membership fees. All medications come from licensed 503A compounding pharmacies—facilities regulated by state boards of pharmacy—ensuring pharmaceutical-grade quality and sterility. PlexusDx serves all 50 states and accepts HSA and FSA accounts for additional savings.
Patients can also opt for oral semaglutide at $249 per month if injections are not preferred. Your dose may need adjustment over time based on tolerance and weight-loss goals, but your monthly price remains flat—there are no per-dose cost increases. After your first month of treatment, consider the PlexusDx Precision Peptide Genetic Test ($99 add-on) to identify genetic variations in GLP1R, GIPR, FTO, and MC4R pathways that predict your individual response to semaglutide therapy.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What exactly is the active ingredient that makes Ozempic cause weight loss?
Semaglutide is the active ingredient—a GLP-1 receptor agonist that suppresses appetite, slows stomach emptying, and improves blood sugar control. These combined effects reduce calorie intake and make weight loss sustainable. PlexusDx delivers compounded semaglutide injections with the same active ingredient as brand Ozempic, starting at $149 monthly.
Does semaglutide in Ozempic affect your metabolism or just your appetite?
Semaglutide affects both appetite and metabolism. It reduces hunger signals in the brain while also improving how your pancreas produces insulin and manages glucose. Clinical trials show users lose weight partly through reduced calorie intake and partly through improved metabolic efficiency, making it more effective than appetite suppression alone.
Is compounded semaglutide from PlexusDx the same as brand-name Ozempic?
PlexusDx compounded semaglutide contains the same active pharmaceutical ingredient as Ozempic but is produced by licensed 503A compounding pharmacies rather than manufactured by the brand company. It delivers equivalent clinical results at a fraction of the cost, with no insurance or membership required.
Are there side effects from the semaglutide in Ozempic?
Common side effects include nausea, constipation, and mild gastrointestinal discomfort, particularly when starting or increasing dose. These typically resolve within weeks as your body adjusts. Serious side effects are rare but may include pancreatitis or allergic reactions. Discuss your full medical history with a healthcare provider before starting semaglutide therapy.
How can I know if my body will respond well to semaglutide?
PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence your response to semaglutide. The test maps 14 peptide pathways and 150+ genetic insights ($99 add-on after first month of treatment), helping personalize your therapy and predict weight-loss outcomes based on your unique genetic profile.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Is an Ozempic Shot? Everything You Need to Know
Knowing When Your Ozempic® Pen Is Empty: A Guide for Consistent Care